Yutaka Suzuki

13PUBLICATIONS
130CO-AUTHORS
Predictive and prognostic markersPlant developmental and reproductive biologyCell metabolismCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Sep 29, 2026
Multiplex Immunofluorescence-defined CXCL13-associated TLS-like Niches Predict Outcome in Bladder Cancer.

|Dec 13, 2025
SWI/SNF chromatin remodeling factor BRAHMA promotes de novo shoot regeneration by epigenetic priming via H3K27me3 removal.

Ayaka Horie, Hikaru Sato, Takuya Sakamoto

|Dec 12, 2024
Mathematical Modeling Predicts Optimal Immune Checkpoint Inhibitor and Radiotherapy Combinations and Timing of Administration.

Shunsuke A Sakai, Koichi Saeki, SungGi Chi

|Apr 18, 2024
CD106 in Tumor-Specific Exhausted CD8+ T Cells Mediates Immunosuppression by Inhibiting TCR Signaling.

Yuto Naoi, Takao Morinaga, Joji Nagasaki

Pageof 3